vTv Therapeutics (VTVT) Return on Invested Capital (2015 - 2017)

vTv Therapeutics (VTVT) reported Return on Invested Capital of 0.02% for Q4 2017, down 91.71% sequentially from 0.01% in Q3 2017.

vTv Therapeutics (VTVT) Return on Invested Capital (2015 - 2017) Analysis & Trends

vTv Therapeutics (VTVT) has 3 years of Return on Invested Capital data on file, last reported at 0.02% in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 0.00%
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 0.04%
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 vTv Therapeutics 19.21 Mn 19.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2017 -0.02%
Sep 30, 2017 -0.01%
Jun 30, 2017 -0.01%
Mar 31, 2017 -0.02%
Mar 31, 2016 -0.01%
Dec 31, 2015 -0.01%